Srage mimetibody, compositions, methods and uses

Details for Australian Patent Application No. 2005289594 (hide)

Owner Centocor, Inc.

Inventors Picha, Kristen; Jordan, Robert; Anderson, Glenn Mark

Agent Shelston IP

Pub. Number AU-B-2005289594

PCT Pub. Number WO2006/036922

Priority 60/613,247 27.09.04 US

Filing date 27 September 2005

Wipo publication date 6 April 2006

Acceptance publication date 2 February 2012

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/036922 Priority application(s): WO2006/036922

2 February 2012 Application Accepted

  Published as AU-B-2005289594

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005289595-Systems and method for virtual host name roaming and managing virtual IP addresses

2005289591-Treatment of neurological deficits in the striatum or substanta nigra pars compacta